# The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum

> **NCT05832580** · PHASE3 · RECRUITING · sponsor: **UMC Utrecht** · enrollment: 76 (estimated)

## Conditions studied

- Pseudoxanthoma Elasticum

## Interventions

- **DRUG:** Etidronate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05832580
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-04-26
- **Primary completion:** 2027-03-29
- **Final completion:** 2027-04-29
- **Target enrollment:** 76 (ESTIMATED)
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05832580

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05832580, "The Prevention of Systemic Ectopic Mineralization in Pseudoxanthoma Elasticum". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05832580. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*